Pandemic's hidden toll: study screens new mothers for postpartum depression

NCT ID NCT04487171

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study screens women who gave birth in four French hospitals for postpartum depression and anxiety during the COVID-19 pandemic. Participants fill out three questionnaires shortly after delivery and again about a month later. The goal is to measure how common postpartum depression is in this context and identify risk factors. The study does not test any treatment, but aims to improve understanding of mental health needs during a public health crisis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could highlight the hidden mental health toll of the pandemic on new mothers and guide better screening practices.
What could go wrong: This is a small observational study with only 38 participants, so findings may not apply broadly. It measures symptoms, not diagnoses, and cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID19 POSTPARTUM DEPRESSION PREVALENCE SOCIAL DISTANCE

Contacts and locations

Locations

CHU Amiens

Amiens, 80480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.